Neogen Corporation (NEOG)

Market Cap	1.34B
Revenue (ttm)	906.00M
Net Income (ttm)	-485.26M
Shares Out	217.04M
EPS (ttm)	-2.24
PE Ratio	n/a
Forward PE	14.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	530,020
Open	6.08
Previous Close	6.20
Day's Range	6.04 - 6.18
52-Week Range	3.87 - 18.58
Beta	1.83
Analysts	Buy
Price Target	9.00 (+45.4%)
Earnings Date	Apr 9, 2025

About NEOG

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residue...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Aug 23, 1989
• Employees: 2,917
• Stock Exchange: NASDAQ
• Ticker Symbol: NEOG
• Website: https://www.neogen.com

Financial Performance

In 2024, Neogen's revenue was $924.22 million, an increase of 12.37% compared to the previous year's $822.45 million. Losses were -$9.42 million, -58.81% less than in 2023.

Analyst Forecast

According to 2 analysts, the average rating for NEOG stock is "Buy." The 12-month stock price forecast is $9.0, which is an increase of 45.40% from the latest price.

Price Target

$9.0

(45.40% upside)

Analyst Consensus: Buy